Excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.
Funding for supplemental payments to hospitals with avoidable patient days under the Medical Assistance program, for enhanced nursing home reimbursement rates under the Medical Assistance program for residents with bariatric and extensive wound care needs, and for the complex patient pilot program. (FE)